A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT06450639 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06450639
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-04
- Primary completion
- 2026-08-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.